loading...| Preferred Name |
osimertinib |
|
| Synonyms |
osimertinib mesilate AZD-9291 AZD9291 mesylate Tagrisso mereletinib AZD-9291 mesylate mereletinib mesylate osimertinib mesylate N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide methanesulfonate (1:1) AZD9291 mereletinib mesilate |
|
| ID |
http://purl.bioontology.org/ontology/MESH/C000596361 |
|
| altLabel |
osimertinib mesilate AZD-9291 AZD9291 mesylate Tagrisso mereletinib AZD-9291 mesylate mereletinib mesylate osimertinib mesylate N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide N-(2-((2-(dimethylamino)ethyl)methylamino)-4-methoxy-5-((4-(1-methyl-1H-indol-3-yl)-2-pyrimidinyl)amino)phenyl)-2-propenamide methanesulfonate (1:1) AZD9291 mereletinib mesilate |
|
| cui |
C4058817 C5557473 C4058811 C4058810 C3896906 |
|
| HM |
D007211 D011743 D000814 D000178 |
|
| Inverse of RB |
3C06JJ0Z2O RDL94R2A16 0 |
|
| isa | ||
| LT |
TRD |
|
| Mapped to |
http://purl.bioontology.org/ontology/MESH/D011743 http://purl.bioontology.org/ontology/MESH/D000178 |
|
| MDA |
20150329 |
|
| MeSH Frequency |
1081 |
|
| MMR |
20220607 |
|
| notation |
C000596361 |
|
| PA |
D047428 D000970 |
|
| prefLabel |
osimertinib |
|
| RR |
RDL94R2A16 |
|
| SC |
1 |
|
| Scope Statement |
an EGFR tyrosine kinase inhibitor |
|
| SRC |
Cancer Discov. 2014 Aug;4(8):OF10. |
|
| TERMUI |
T001121132 T001121131 T001121229 T001121133 T000892956 T001121230 T001121232 T001121227 T001121130 T000892955 T001121228 T001121226 T000877552 |
|
| TH |
NLM (2016) FDA SRS (2017) NLM (2015) NLM (2022) USAN (19XX) INN (19XX) |
|
| tui |
T109 T121 |